Both cases received oseltamivir treatment.
二者都接受了奥司他韦治疗。
The clinical value of oseltamivir has been questioned.
奥司他韦的临床价值受到了质疑。
Could the virus become resistant to oseltamivir and zanamivir?
病毒会不会对达菲和扎那米韦产生抗药性？
Oseltamivir remains the drug of first choice recommended by WHO.
奥司他韦仍然是世卫组织推荐的首选药物。
On 21 December they began receiving 2 tablets per day of oseltamivir.
12月21日，他们均开始每天服用两片奥斯他韦。
The viruses, while resistant to oseltamivir, remain sensitive to zanamivir.
这些病毒对奥司他韦具有耐药性，但对扎那米韦仍是敏感的。
All other viruses have been shown sensitive to both oseltamivir and zanamivir.
所有其它病毒显示对奥司他韦和扎那米韦都是敏感的。
Some 100,000 treatment courses of oseltamivir (Tamiflu) arrived in Turkey Friday evening.
约10万疗程的奥司他韦(达菲)于星期五傍晚抵达土耳其。
Where oseltamivir is unavailable or cannot be used for any reason, zanamivir may be given.
在没有奥司他韦或者无论如何不能使用奥司他韦时，可用扎那米韦治疗。
At this time there is no indication that oseltamivir resistance is widespread in Egypt or elsewhere.
目前无迹象表明奥斯他韦耐药性在埃及或其它地方普遍存在。
She was admitted to hospital on 21 July, placed on a ventilator, and received oseltamivir treatment.
她于7月21日被收住入院，使用了呼吸机并接受了奥司他韦治疗。
She was admitted to Tanta Fever Hospital where she received oseltamivir treatment on the same day.
她被收住到坦塔发热医院，并在同日接受了奥司他韦治疗。
WHO has been informed of two recent clusters of patients infected with oseltamivir-resistant H1N1 viruses.
世卫组织接到通报说，最近有两组患者感染了对奥司他韦具有耐药性的H1N1病毒。
Patients who have severe or deteriorating influenza should be treated as soon as possible with oseltamivir.
对那些患有严重流感或流感病情恶化的病人，应尽快使用奥司他韦加以治疗。
She developed symptoms on 22 December, was hospitalized on 23 December and received treatment with oseltamivir.
她于2010年12月22日出现症状，12月23日入院并接受了奥司他韦治疗。
She developed symptoms on 6 January and was hospitalized on 11 January, where she received oseltamivir treatment.
她于1月6日出现症状，1月11日入院并接受奥司他韦治疗。
In addition, community surveillance for oseltamivir-resistant pandemic H1N1 virus strains should be enhanced.
此外，应该加强对奥司他韦具有耐药性的H1N1大流行性流感病毒株的社区监督。
She developed symptoms on 31 January and was hospitalized on 2 February, where she received oseltamivir treatment.
她于1月31日出现症状，2月2日入院并接受奥司他韦治疗。
A further two were isolated from patients who were not taking oseltamivir for either treatment or prophylaxis.
还有两个病毒来自并未采用奥斯他韦进行治疗或预防的患者。
She developed symptoms on 27 January and was hospitalized on 3 February, where she received oseltamivir treatment.
她于1月27日出现症状，2月3日入院并接受奥司他韦治疗。
He developed symptoms on 7 January and was hospitalized on 12 January, where he received oseltamivir treatment.
他于1月7日出现症状，1月12日入院并接受奥司他韦治疗。
He developed symptoms on 12 January and was hospitalized on 19 January, where he received oseltamivir treatment.
他于1月12日出现症状，1月19日入院并接受奥司他韦治疗。
He developed symptoms on 19 January and was hospitalized on 21 January, where he received oseltamivir treatment.
他于1月19日出现症状，1月21日入院并接受奥司他韦治疗。
To date, person-to-person transmission of these oseltamivir resistant viruses has not been conclusively demonstrated.
迄今为止，尚无确凿证据显示这些对奥司他韦具有耐药性的病毒已在人际传播。
Both cases were admitted to Zagazig Fever Hospital where they received oseltamivir and are in a stable condition.
这两个病例均被Zagazig发热医院收治并使用奥司他韦进行治疗，目前病情稳定。
He developed symptoms on 22 February and was hospitalized on 23 February, where he received oseltamivir treatment.
他于2月22日出现症状，2月23日被收住入院并接受奥司他韦治疗。
He developed symptoms on 27 February and was hospitalized on 27 February, where he received oseltamivir treatment.
他于2月27日出现症状，2月27日被收住入院并接受奥司他韦治疗。
He developed symptoms on 10 February and was hospitalized on 14 February, where he received oseltamivir treatment.
他于2月10日出现症状，2月14日被收住入院并接受奥司他韦治疗。
One hundred thousand treatment courses of oseltamivir were delivered one day after the first cases were confirmed.
在最初确认病例的一天之后，就提供了10万个疗程的奥塞·米韦。
She developed symptoms on 6 February and was hospitalized on 12 February, where she received oseltamivir treatment.
她于2月6日出现症状，2月12日被收住入院并接受奥司他韦治疗。
应用推荐